All lobbying filings
Bell & Lindsay, Inc.
Bell & Lindsay, Inc. filed a Q2 report for Vivos Therapeutics, Inc. on July 21, 2025, reporting $40,000 in lobbying income.
Lobbying for Vivos Therapeutics, Inc. · Medical technology company focused on sleeping and breathing disorders.
Filing · LD-2 quarterly report
Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 21, 2025
Income
$40,000
What the client paid this registrant for the period.
Client based in
Colorado
Lobbyists on this filing
1
-
MARK F LINDSAYPreviously held: Assistant to the President The White House
Government bodies contacted
4
Lobbying activity
1
General consulting